Copyright Reports & Markets. All rights reserved.

Global Dermatology OTC medications Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Dermatology OTC medications Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Dermatology OTC medications Market Size Growth Rate by Product
      • 1.4.2 Sun screens
      • 1.4.3 Anti-aging
      • 1.4.4 Wrinkle cream
      • 1.4.5 Acne Treatment
      • 1.4.6 others
    • 1.5 Market by End User
      • 1.5.1 Global Dermatology OTC medications Market Size Growth Rate by End User
      • 1.5.2 male
      • 1.5.3 female
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Dermatology OTC medications Market Size
      • 2.1.1 Global Dermatology OTC medications Revenue 2014-2025
      • 2.1.2 Global Dermatology OTC medications Sales 2014-2025
    • 2.2 Dermatology OTC medications Growth Rate by Regions
      • 2.2.1 Global Dermatology OTC medications Sales by Regions
      • 2.2.2 Global Dermatology OTC medications Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Dermatology OTC medications Sales by Manufacturers
      • 3.1.1 Dermatology OTC medications Sales by Manufacturers
      • 3.1.2 Dermatology OTC medications Sales Market Share by Manufacturers
      • 3.1.3 Global Dermatology OTC medications Market Concentration Ratio (CR5 and HHI)
    • 3.2 Dermatology OTC medications Revenue by Manufacturers
      • 3.2.1 Dermatology OTC medications Revenue by Manufacturers (2014-2019)
      • 3.2.2 Dermatology OTC medications Revenue Share by Manufacturers (2014-2019)
    • 3.3 Dermatology OTC medications Price by Manufacturers
    • 3.4 Dermatology OTC medications Manufacturing Base Distribution, Product Types
      • 3.4.1 Dermatology OTC medications Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Dermatology OTC medications Product Type
      • 3.4.3 Date of International Manufacturers Enter into Dermatology OTC medications Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Dermatology OTC medications Sales by Product
    • 4.2 Global Dermatology OTC medications Revenue by Product
    • 4.3 Dermatology OTC medications Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Dermatology OTC medications Breakdown Data by End User

    6 North America

    • 6.1 North America Dermatology OTC medications by Countries
      • 6.1.1 North America Dermatology OTC medications Sales by Countries
      • 6.1.2 North America Dermatology OTC medications Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Dermatology OTC medications by Product
    • 6.3 North America Dermatology OTC medications by End User

    7 Europe

    • 7.1 Europe Dermatology OTC medications by Countries
      • 7.1.1 Europe Dermatology OTC medications Sales by Countries
      • 7.1.2 Europe Dermatology OTC medications Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Dermatology OTC medications by Product
    • 7.3 Europe Dermatology OTC medications by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Dermatology OTC medications by Countries
      • 8.1.1 Asia Pacific Dermatology OTC medications Sales by Countries
      • 8.1.2 Asia Pacific Dermatology OTC medications Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Dermatology OTC medications by Product
    • 8.3 Asia Pacific Dermatology OTC medications by End User

    9 Central & South America

    • 9.1 Central & South America Dermatology OTC medications by Countries
      • 9.1.1 Central & South America Dermatology OTC medications Sales by Countries
      • 9.1.2 Central & South America Dermatology OTC medications Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Dermatology OTC medications by Product
    • 9.3 Central & South America Dermatology OTC medications by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Dermatology OTC medications by Countries
      • 10.1.1 Middle East and Africa Dermatology OTC medications Sales by Countries
      • 10.1.2 Middle East and Africa Dermatology OTC medications Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Dermatology OTC medications by Product
    • 10.3 Middle East and Africa Dermatology OTC medications by End User

    11 Company Profiles

    • 11.1 Beiersdorf
      • 11.1.1 Beiersdorf Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Beiersdorf Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Beiersdorf Dermatology OTC medications Products Offered
      • 11.1.5 Beiersdorf Recent Development
    • 11.2 Lancaster Beauty
      • 11.2.1 Lancaster Beauty Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Lancaster Beauty Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Lancaster Beauty Dermatology OTC medications Products Offered
      • 11.2.5 Lancaster Beauty Recent Development
    • 11.3 loreal
      • 11.3.1 loreal Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 loreal Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 loreal Dermatology OTC medications Products Offered
      • 11.3.5 loreal Recent Development
    • 11.4 Johnson & Johnson
      • 11.4.1 Johnson & Johnson Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Johnson & Johnson Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Johnson & Johnson Dermatology OTC medications Products Offered
      • 11.4.5 Johnson & Johnson Recent Development
    • 11.5 Obagi Medical Products
      • 11.5.1 Obagi Medical Products Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Obagi Medical Products Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Obagi Medical Products Dermatology OTC medications Products Offered
      • 11.5.5 Obagi Medical Products Recent Development
    • 11.6 Bayer
      • 11.6.1 Bayer Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Bayer Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Bayer Dermatology OTC medications Products Offered
      • 11.6.5 Bayer Recent Development
    • 11.7 Shiseido
      • 11.7.1 Shiseido Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Shiseido Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Shiseido Dermatology OTC medications Products Offered
      • 11.7.5 Shiseido Recent Development
    • 11.8 Amway
      • 11.8.1 Amway Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Amway Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Amway Dermatology OTC medications Products Offered
      • 11.8.5 Amway Recent Development
    • 11.9 Avon Products
      • 11.9.1 Avon Products Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Avon Products Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Avon Products Dermatology OTC medications Products Offered
      • 11.9.5 Avon Products Recent Development
    • 11.10 Clarins
      • 11.10.1 Clarins Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Clarins Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Clarins Dermatology OTC medications Products Offered
      • 11.10.5 Clarins Recent Development
    • 11.11 Edgewell Personal Care
    • 11.12 Lotus Herbals
    • 11.13 Proctor & Gamble
    • 11.14 Revlon
    • 11.15 COOLA SUNCARE
    • 11.16 Sebapharma
    • 11.17 Clinique Laboratories
    • 11.18 Sisley Paris
    • 11.19 Avene

    12 Future Forecast

    • 12.1 Dermatology OTC medications Market Forecast by Regions
      • 12.1.1 Global Dermatology OTC medications Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Dermatology OTC medications Revenue Forecast by Regions 2019-2025
    • 12.2 Dermatology OTC medications Market Forecast by Product
      • 12.2.1 Global Dermatology OTC medications Sales Forecast by Product 2019-2025
      • 12.2.2 Global Dermatology OTC medications Revenue Forecast by Product 2019-2025
    • 12.3 Dermatology OTC medications Market Forecast by End User
    • 12.4 North America Dermatology OTC medications Forecast
    • 12.5 Europe Dermatology OTC medications Forecast
    • 12.6 Asia Pacific Dermatology OTC medications Forecast
    • 12.7 Central & South America Dermatology OTC medications Forecast
    • 12.8 Middle East and Africa Dermatology OTC medications Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Dermatology OTC medications Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Dermatology OTC medications market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dermatology OTC medications market based on company, product type, end user and key regions.

      This report studies the global market size of Dermatology OTC medications in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dermatology OTC medications in these regions.
      This research report categorizes the global Dermatology OTC medications market by top players/brands, region, type and end user. This report also studies the global Dermatology OTC medications market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Beiersdorf
      Lancaster Beauty
      loreal
      Johnson & Johnson
      Obagi Medical Products
      Bayer
      Shiseido
      Amway
      Avon Products
      Clarins
      Edgewell Personal Care
      Lotus Herbals
      Proctor & Gamble
      Revlon
      COOLA SUNCARE
      Sebapharma
      Clinique Laboratories
      Sisley Paris
      Avene

      Market size by Product
      Sun screens
      Anti-aging
      Wrinkle cream
      Acne Treatment
      others
      Market size by End User
      male
      female

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Dermatology OTC medications market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Dermatology OTC medications market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Dermatology OTC medications companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Dermatology OTC medications submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Dermatology OTC medications are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dermatology OTC medications market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now